GlassScriptPhysician profile
Niall A Smyth
NPI 1720321524
$24,323.19
in general payments reported to CMS, 2019-2025
12 companies · $20K in 2025
The $20K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,193 · 2020: $447 · 2022: $208 · 2023: $1,692 · 2024: $607 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $5,381 · Food and Beverage: $2,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,000.00 |
| Travel and Lodging | $5,380.81 |
| Food and Beverage | $2,094.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21,086.19 | 2022-2025 | Prostep, Infinity, 7 X 23mm Citrelock Implant |
| Paragon 28, INC. | $2,329.87 | 2019-2025 | Portfolio, Additive Orthopedics, Phantom Fibula Nail |
| Exactech, INC. | $434.65 | 2020 | |
| Arteriocyte Medical Systems, INC. | $294.37 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $29.50 | 2025 | Zilretta, Iovera |
| Vertex Pharmaceuticals Incorporated | $26.70 | 2025 | |
| Bioventus LLC | $25.67 | 2025 | Durolane |
| Treace Medical Concepts, INC. | $23.17 | 2023 | |
| Depuy Synthes Sales INC. | $21.96 | 2025 | Dynaforce |
| Wright Medical Technology, INC. | $21.17 | 2019 | |
| Djo, LLC | $17.37 | 2024 | Cmf |
| Amniox Medical, INC. | $12.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niall Smyth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.